Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Sema4 Holdings Corp. (SMFR) Stock Forecast & Price Prediction United States | NASDAQ | |
$63.61
+4.16 (7.00%)10 Quality Stocks Worth Considering Now
Researching Sema4 (SMFR) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on SMFR and similar high-potential opportunities.
SMFR has shown a year-to-date change of -17.2% and a 1-year change of 184.1%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for SMFR. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for SMFR.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Dec 7, 2022 | Goldman Sachs | Matthew Sykes | Neutral | Downgrade | $1.00 |
Nov 15, 2022 | Cowen & Co. | Max Masucci | Outperform | Maintains | $3.00 |
Aug 18, 2022 | BTIG | Mark Massaro | Buy | Maintains | $3.00 |
Aug 16, 2022 | Jefferies | Brandon Couillard | Hold | Downgrade | $2.00 |
May 16, 2022 | Cowen & Co. | Max Masucci | Outperform | Maintains | $5.00 |
Nov 19, 2021 | Goldman Sachs | Buy | Initiates | $0.00 | |
Oct 8, 2021 | BTIG | Buy | Initiates | $0.00 | |
Sep 30, 2021 | Cowen & Co. | Outperform | Initiates | $0.00 | |
Sep 24, 2021 | Jefferies | Buy | Initiates | $0.00 |
The following stocks are similar to Sema4 based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Sema4 Holdings Corp. has a market capitalization of $6.87B with a P/E ratio of 1.6x. The company generates $212.20M in trailing twelve-month revenue with a -7.8% profit margin.
Revenue growth is +130.1% quarter-over-quarter, while maintaining an operating margin of -114.3% and return on equity of +42.6%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Sema4.ai has launched its full-stack enterprise AI agent platform, now available for general use.
Sema4.ai's launch of its enterprise AI agent platform signals potential growth and competitive advantage in the AI sector, impacting stock valuations and investment strategies.
Sema4.ai has been recognized as a Sample Vendor in Gartner's 2024 Hype Cycles for Enterprise Applications and AI in Software Engineering, highlighting its contributions to AI agent technology.
Recognition by Gartner boosts Sema4.ai's credibility and visibility in the AI sector, potentially attracting investment and partnerships, which can enhance growth prospects.
Sema4.ai has raised $30.5 million in funding to enhance enterprise work through open source AI, focusing on intelligent agents for collaboration among knowledge workers.
Sema4.ai's $30.5 million funding enhances its position in the AI sector, potentially boosting productivity in enterprises and signaling growth opportunities in the evolving tech landscape.
Sema4, Inc. announced that its subsidiary, House Hanover LLC, has been appointed as Liquidation Trustee for Melody Capital Partners, confirmed by a Delaware Chancery Court order on February 10, 2023.
Sema4's subsidiary taking on the role of Liquidation Trustee signals potential asset liquidation, impacting investors' expectations for recovery and future valuations.
Sema4 (Nasdaq: SMFR) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 10:30 a.m. PT, led by CEO Katherine Stueland.
Sema4's participation in a major healthcare conference signals potential growth and innovation, attracting investor interest and impacting stock performance.
Sema4's restructuring may negatively impact cash flow in upcoming quarters, with CEO removal indicating a shift towards short-term survival over long-term growth.
Sema4's restructuring and CEO change may indicate cash flow challenges and a shift to short-term strategies, potentially impacting future growth and investor confidence.
Analyst forecasts for Sema4 Holdings Corp. (SMFR) are not currently available. The stock is trading at $63.61.
Analyst ratings for SMFR are not currently available. The stock is currently trading at $63.61. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for SMFR are not currently available. The stock is trading at $63.61.
N/A
Price targets from Wall Street analysts for SMFR are not currently available. The stock is trading at $63.61.
Price targets from Wall Street analysts for SMFR are not currently available. The stock is trading at $63.61.
Analyst ratings for SMFR are not currently available. The stock is trading at $63.61.
Stock price projections, including those for Sema4 Holdings Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.